Name | omidenepag |
---|---|
Synonyms |
UNII-Z95F9F9LU4
Z95F9F9LU4 UR-7276 Glycine, N-[6-[[[[4-(1H-pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]-2-pyridinyl]- N-[6-({[4-(1H-Pyrazol-1-yl)benzyl](3-pyridinylsulfonyl)amino}methyl)-2-pyridinyl]glycine N-{6-[(N-{[4-(1H-pyrazol-1-yl)phenyl]methyl}pyridine-3-sulfonamido)methyl]pyridin-2-yl}glycine omidenepag |
Description | Omidenepag,a pharmacologically active form of Omidenepag Isopropyl, is a selective, non-prostanoid EP2 receptor agonist, with an EC50 of 1.1 nM. Omidenepag shows binding affinities (IC50) 10 nM for h-EP2[1]. |
---|---|
Related Catalog | |
Target |
EP2:1.1 nM (EC50) h-EP1:10 nM (IC50) h-EP4:5480 nM (IC50) |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 769.4±70.0 °C at 760 mmHg |
Molecular Formula | C23H22N6O4S |
Molecular Weight | 478.524 |
Flash Point | 419.1±35.7 °C |
Exact Mass | 478.142334 |
LogP | 1.75 |
Vapour Pressure | 0.0±2.8 mmHg at 25°C |
Index of Refraction | 1.680 |